) The Data Management Core at the Moffitt Cancer Center has three main functions: A. Assistance in patient enrollment and treatment on clinical trials B. Clinical trials data management C. Quality assurance of data Clinical trials data management is centrally directed, yet based in the interdisciplinary clinical programs where the DMC staff function as members of the multidisciplinary teams. In addition to the functions noted above, the DMC is responsible for recruitment and training of clinical research staff. Staff assignments are based upon accrual, utilizing a staffing ratio of approximately 40 patient accruals (therapeutic) to 1.0 FTE. Annual patient accrual of the Cancer Center for fiscal year ?99 exceeds 3700, with over 975 patients on therapeutic studies. In addition to CCSG support, the data management core is supported with institutional funds and charge-back revenue from industrial studies and cooperative groups. The Cancer Center has committed substantial support to Data Management functions and the Clinical Trials Finance Office has been successful in recovering significant support from pharmaceutical studies for this purpose. However, institutionally based, peer reviewed studies will continue to grow, especially with the Phase I/II Clinical Research Unit expansion. The increase in patient accrual, especially to innovative phase I/II clinical trials, and the additional burdens of an increasing population to follow requires additional staff. We are requesting a total of 1.35 FTE.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA076292-04
Application #
6430488
Study Section
Project Start
1998-02-19
Project End
2006-01-31
Budget Start
Budget End
Support Year
4
Fiscal Year
2001
Total Cost
$305,280
Indirect Cost
Name
University of South Florida
Department
Type
DUNS #
City
Tampa
State
FL
Country
United States
Zip Code
33612
de Mingo Pulido, Álvaro; Gardner, Alycia; Hiebler, Shandi et al. (2018) TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer. Cancer Cell 33:60-74.e6
Divakaran, Anand; Talluri, Siva K; Ayoub, Alex M et al. (2018) Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor. J Med Chem 61:9316-9334
McIntyre, Jessica; Jiménez, Julio; Rivera, Yonaira M et al. (2018) Comparison of Health Communication Channels for Reaching Hispanics About Biobanking: a Pilot Trial. J Cancer Educ 33:833-841
Li, Gongbo; Boucher, Justin C; Kotani, Hiroshi et al. (2018) 4-1BB enhancement of CAR T function requires NF-?B and TRAFs. JCI Insight 3:
Rivera, Y M; Moreno, L; Briant, K J et al. (2018) Developing Sustainable Cancer Education Programs: Training Public Health Students to Deliver Cancer 101 in Puerto Rico. J Cancer Educ 33:128-133
Saltos, Andreas; Khalil, Farah; Smith, Michelle et al. (2018) Clinical associations of mucin 1 in human lung cancer and precancerous lesions. Oncotarget 9:35666-35675
Gjyshi, Anxhela; Dash, Sweta; Cen, Ling et al. (2018) Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine. Sci Rep 8:8291
Maharaj, Kamira; Powers, John J; Achille, Alex et al. (2018) Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia. Blood Adv 2:3012-3024
Schaal, Courtney M; Bora-Singhal, Namrata; Kumar, Durairaj Mohan et al. (2018) Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer. Mol Cancer 17:149
Zhu, Genyuan; Brayer, Jason; Padron, Eric et al. (2018) OMIP-049: Analysis of Human Myelopoiesis and Myeloid Neoplasms. Cytometry A 93:982-986

Showing the most recent 10 out of 1254 publications